ISSN: 2044-9038 (Print) 2044-9046 (Electronic)

Clinical Practice

Pneumonia Infection

Mycoplasma pneumonia is an omnipresent respiratory bacterium that causes network procured pneumonia and other respiratory sickness. Neurological sequelae happen in up to 7% of patients with M pneumonia diseases and incorporate meningoencephalitis, incendiary neuropathies and transverse myelitis. Distinctive invulnerable systems may represent this heterogeneity. Apparently Mycoplasma Associated Meningitis (MAM) either happens early, perhaps because of bacterial intrusion of the CNS or late auxiliary to a speculated post-irresistible safe wonder. We present an instance of early M pneumonia meningitis and myelitis that neglected to show clinical improvement with coordinated antimicrobial treatment yet reacted to corticosteroids. A multiyear old Aboriginal male introduced to a provincial medical clinic in New South Wales, Australia with 24 hours of fever (39.3°C), frontal migraine, neck torment, heaving and photophobia. The patient denied ongoing travel or intravenous medication use and was not immunosuppressed. He had an upper respiratory tract contamination four days preceding introduction. Regardless of treatment with intravenous ceftriaxone (1gm every day) and oral doxycycline (100 mg day by day) the high fevers and meningitic side effects continued. Following five days, intravenous benzylpenicillin, acyclovir and vancomycin were included yet without impact.    

High Impact List of Articles

Relevant Topics in Clinical